LINC01133 and Its Role in Laryngeal Cancer
Author Information
Author(s): Razipour Masoumeh, Jamali Zeinab, Sohrabpour Saeed, Heidari Farrokh, Lotfi Maryam, Ghadami Elham, Abtin Maryam, Maghsudlu Mohaddese, Sahebi Leyla, Shakoori Abbas
Primary Institution: Tehran University of Medical Sciences
Hypothesis
The study aimed to investigate the expression, clinical significance, and potential functions of the LINC01133 in laryngeal squamous cell carcinoma (LSCC).
Conclusion
LINC01133 is downregulated in LSCC tissues and its decreased expression is associated with advanced tumor stages and lymph node metastasis.
Supporting Evidence
- LINC01133 was significantly downregulated in 73% of tumor samples compared to adjacent normal tissues.
- Decreased LINC01133 expression was associated with advanced tumor stage (p=0.0206) and lymph node metastasis (p=0.0203).
- The ROC curve analysis indicated potential diagnostic utility with an AUC of 0.7115 (p=0.001).
Takeaway
LINC01133 is like a superhero gene that helps stop cancer, but in laryngeal cancer, it doesn't work well, which might make the cancer grow faster.
Methodology
The study used quantitative real-time PCR to analyze LINC01133 expression in 41 pairs of LSCC tissues and adjacent normal tissues.
Potential Biases
Potential biases may arise from differences in patient cohorts and technical issues in data collection.
Limitations
The study did not explore the expression of LINC01133 in other stages of LSCC or in other types of head and neck cancers.
Participant Demographics
All participants were patients with laryngeal squamous cell carcinoma, with no specific demographic details provided.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI=0.6004 to 0.8226
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website